Bank Of New York Mellon Corp Orgenesis Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	BUY	$4.77 - $8.08 $26,025 - $44,084	5,456 Added 12.37%	49,566 $284,000
Q4 2020 Feb 09, 2021	SELL	$4.4 - $5.63 $10,128 - $12,960	-2,302 Reduced 4.96%	44,110 $198,000
Q3 2020 Nov 12, 2020	BUY	$4.75 - $5.99 $289 - $365	61 Added 0.13%	46,412 $233,000
Q2 2020 Aug 12, 2020	BUY	$3.6 - $7.84 $166,863 - $363,391	46,351 New	46,351 $281,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $32.2M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.